Instead, the 95% CIs were used to indicate statistical significance if the 95% CIs did not overlap with the mean of the alternative treatment, and differences were designated as highly significant when the 95% CIs of the 2 different treatments did not overlap at all.
← all excerpts
The factor XIa antibody osocimab strongly inhibits clotting in extracorporeal circuits with human blood and in baboons.
1
—
—